Overview
Egidia Costanzi practices practicing medicine in Perugia, Italy.
Their clinical expertise encompasses Primary Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), and Prostate Cancer.
They are actively involved in clinical research, co-authoring 19 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Egidia Costanzi
Is Egidia Costanzi a top-rated expert for Primary Lateral Sclerosis?
MediFind is an objective health platform that identifies experts based on real-world data. Egidia Costanzi is classified as an Experienced expert for Primary Lateral Sclerosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Egidia Costanzi participate in research or clinical trials?
Yes. Egidia Costanzi has published 19 articles and abstracts on conditions like Primary Lateral Sclerosis. You can view a list of Egidia Costanzi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)
- Primary Lateral SclerosisCostanzi isExperienced. Learn about Primary Lateral Sclerosis.
- Prostate CancerCostanzi isExperienced. Learn about Prostate Cancer.